AdaptHealth (NASDAQ:AHCO) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS

AdaptHealth (NASDAQ:AHCO) issued its quarterly earnings data on Tuesday. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.25 by $0.12, Zacks reports. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. AdaptHealth updated its FY 2025 guidance to EPS.

AdaptHealth Trading Up 1.2 %

Shares of AdaptHealth stock opened at $8.55 on Tuesday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The firm has a 50-day moving average of $9.83 and a 200-day moving average of $10.19. AdaptHealth has a 52-week low of $7.25 and a 52-week high of $11.90. The stock has a market cap of $1.15 billion, a PE ratio of -5.18, a PEG ratio of 1.08 and a beta of 1.12.

Analyst Ratings Changes

AHCO has been the topic of a number of recent research reports. Royal Bank of Canada dropped their target price on AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 19th. UBS Group lowered their target price on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Robert W. Baird cut their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research note on Wednesday, November 6th. Canaccord Genuity Group lowered their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Finally, Truist Financial cut their price objective on AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Friday, November 15th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth currently has a consensus rating of “Buy” and a consensus price target of $12.20.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.